Resveratrol nanoformulation for cancer prevention and therapy

Annals of the New York Academy of Sciences

Volumn 1348, Issue 1, 2015, Pages 20-31

  Siddiqui, Imtiaz A ^a   Sanna, Vanna ^b   Ahmad, Nihal ^a   Sechi, Mario ^b   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

chemoprevention; drug delivery; nanochemoprevention; nanoformulation; resveratrol

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CHITOSAN NANOPARTICLE; CURCUMIN; CYCLOSPORIN A; EPIGALLOCATECHIN GALLATE; FISETIN; FLAVONOID; FLUOROURACIL; GOLD NANOPARTICLE; LIPOSOME; NANOCAPSULE; NANOCARRIER; NANOPARTICLE; NATURAL PRODUCT; PHENOL DERIVATIVE; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; RESVERATROL; SOLID LIPID NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CHEMOTHERAPY; CANCER THERAPY; CARCINOGENESIS; CHEMOPROPHYLAXIS; CYTOTOXICITY; DIET; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; FOOD COMPOSITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; NANOENCAPSULATION; NANOFORMULATION; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; SUSTAINED DRUG RELEASE;

EID: 84932627269     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12811     Document Type: Article

References (68)

1. Adhami, V.M. & H. Mukhtar. 2013. Human cancer chemoprevention: hurdles and challenges. Top. Curr. Chem. 329: 203–220.
2. Mukhtar, H. 2012. Chemoprevention: making it a success story for controlling human cancer. Cancer Lett. 326: 123–127.
3. Sporn, M.B. & N. Suh. 2002. Chemoprevention: an essential approach to controlling cancer. Nat. Rev. Cancer 2: 537–543.
4. Blagosklonny, M.V. 2005. Carcinogenesis, cancer therapy and chemoprevention. Cell Death Differ. 12: 592–602.
5. Scalbert, A., et al. 2005. Dietary polyphenols and the prevention of diseases. Criti. Rev. Food Sci. Nutr. 45: 287–306.
6. Gusman, J., H. Malonne & G. Atassi. 2001. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22: 1111–1117.
7. Aziz, M.H., R. Kumar & N. Ahmad. 2003. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23: 17–28.
8. Sanna, V., et al. 2012. Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol. Int. J. Nanomedicine 7: 5501–5516.
9. Siddiqui, I.A., et al. 2009. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 69: 1712–1716.
10. Siddiqui, I.A. & H. Mukhtar. 2010. Nanochemoprevention by bioactive food components: a perspective. Pharm. Res. 27: 1054–1060.
11. Surh, Y.J. 2003. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3: 768–780.
12. Adhami, V.M., H.H. Bailey & H. Mukhtar. 2014. Cancer chemoprevention is not a failure. Carcinogenesis 35: 2154–2155.
13. Steward, W.P. & K. Brown. 2013. Cancer chemoprevention: a rapidly evolving field. Br. J. Cancer 109: 1–7.
14. Siddiqui, I.A., et al. 2008. Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Chem. Biol. Interact. 171: 122–132.
15. Russo, G.L. 2007. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem. Pharmacol. 74: 533–544.
16. Surh, Y.J. 2004. Transcription factors in the cellular signaling network as prime targets of chemopreventive phytochemicals. Cancer Res.Treat. 36: 275–286.
17. Landis-Piwowar, K.R. & N.R. Iyer. 2014. Cancer chemoprevention: current state of the art. Cancer Growth Metastasis 7: 19–25.
18. Bode, A.M. & Z. Dong. 2000. Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol. 1: 181–188.
19. Dorai, T. & B.B. Aggarwal. 2004. Role of chemopreventive agents in cancer therapy. Cancer Lett. 215: 129–140.
20. Weng, C.J. & G.C. Yen. 2012. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev. 38: 76–87.
21. Weng, C.J. & G.C. Yen. 2012. Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev. 31: 323–351.
22. Liu, R.H. 2013. Dietary bioactive compounds and their health implications. J. Food Sci. 78(Suppl 1): A18–A25.
23. Lall, R.K., et al. 2015. Dietary polyphenols in prevention and treatment of prostate cancer. Int. J. Mol. Sci. 16: 3350–3376.
24. Manach, C., et al. 2004. Polyphenols: food sources and bioavailability. Am. J Clin. Nutr. 79: 727–747.
25. Jang, M., et al. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218–220.
26. Shukla, Y. & R. Singh. 2011. Resveratrol and cellular mechanisms of cancer prevention. Ann. N.Y. Acad. Sci. 1215: 1–8.
27. Holmes-McNary, M. & A.S. Baldwin, Jr. 2000. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res. 60: 3477–3483.
28. Reagan-Shaw, S., H. Mukhtar & N. Ahmad. 2008. Resveratrol imparts photoprotection of normal cells and enhances the efficacy of radiation therapy in cancer cells. Photochem. Photobiol. 84: 415–421.
29. Whitsett, T., M. Carpenter & C.A. Lamartiniere. 2006. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J. Carcinogenesis 5: 15.
30. Garvin, S., K. Ollinger & C. Dabrosin. 2006. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett. 231: 113–122.
31. Provinciali, M., et al. 2005. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int. J. Cancer 115: 36–45.
32. Bishayee, A. 2009. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prevent Res. 2: 409–418.
33. Tome-Carneiro, J., et al. 2013. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr. Pharm. Des. 19: 6064–6093.
34. Carter, L.G., J.A. D'Orazio & K.J. Pearson. 2014. Resveratrol and cancer: focus on in vivo evidence. Endocrine-Related Cancer 21: R209–R225.
35. Francioso, A., et al. 2014. Chemistry, stability and bioavailability of resveratrol. Med. Chem. 10: 237–245.
36. Wenzel, E. & V. Somoza. 2005. Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 49: 472–481.
37. Walle, T. 2011. Bioavailability of resveratrol. Ann. N. Y. Acad. Sci. 1215: 9–15.
38. Amri, A., et al. 2012. Administration of resveratrol: what formulation solutions to bioavailability limitations? J. Control. Release 158: 182–193.
39. Blanco, E., et al. 2011. Nanomedicine in cancer therapy: innovative trends and prospects. Cancer Sci. 102: 1247–1252.
40. Peer, D., et al. 2007. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2: 751–760.
41. Sanna, V., et al. 2013. Nanoformulation of natural products for prevention and therapy of prostate cancer. Cancer Lett. 334: 142–151.
42. Dreaden, E.C., et al. 2012. Size matters: gold nanoparticles in targeted cancer drug delivery. Ther. Deliv. 3: 457–478.
43. Knop, K., et al. 2010. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angewandte Chemie. 49: 6288–6308.
44. Zavaleta, C.L., et al. 2009. Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 106: 13511–13516.
45. Banerjee, S., et al. 2008. Multi-targeted therapy of cancer by genistein. Cancer Lett. 269: 226–242.
46. Sanna, V., N. Pala & M. Sechi. 2014. Targeted therapy using nanotechnology: focus on cancer. Int. J. Nanomedicine 9: 467–483.
47. Kim, B.Y., J.T. Rutka & W.C. Chan. 2010. Nanomedicine. N. Engl. J Med. 363: 2434–2443.
48. Lee, W.H., et al. 2014. Recent advances in curcumin nanoformulation for cancer therapy. Exp. Opin. Drug Deliv. 11: 1183–1201.
49. Pulliero, A., et al. 2015. Nanoparticles increase the efficacy of cancer chemopreventive agents in cells exposed to cigarette smoke condensate. Carcinogenesis 36: 368–377.
50. Sanna, V., et al. 2013. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment. Mol. Pharm. 10: 3871–3881.
51. Xu, W., et al. 2013. Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy. Nanoscale 5: 9924–9933.
52. Summerlin, N., et al. 2015. Resveratrol nanoformulations: challenges and opportunities. Int. J. Pharm. 479: 282–290.
53. Singh, G. & R. S. Pai. 2014. Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS. J. Control. Release 194: 178–188.
54. Wicki, A., et al. 2015. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J. Control. Release 200: 138–157.
55. Yao, Q., et al. 2006. [Study on the preparation of resveratrol chitosan nanoparticles with free amino groups on the surface]. China J. Chin. Mater. Med. 31: 205–208.
56. Shao, J., et al. 2009. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf. B Biointerfaces 72: 40–47.
57. Lu, X., et al. 2009. Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress. Int. J. Pharm. 375: 89–96.
58. Teskac, K. & J. Kristl. 2010. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 390: 61–69.
59. Kobierski, S., et al. 2009. Resveratrol nanosuspensions for dermal application–production, characterization, and physical stability. Die Pharmazie 64: 741–747.
60. Narayanan, N.K., et al. 2009. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer 125: 1–8.
61. Neves, A.R., et al. 2013. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomedicine 8: 177–187.
62. Mohan, A., et al. 2014. Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma. BioMed Res. Int. 2014: 424239.
63. Guo, L., et al. 2010. Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice. Cancer Biother. Radiopharm. 25: 471–477.
64. Figueiro, F., et al. 2013. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J. Biomed. Nanotechnol. 9: 516–526.
65. Sanna, V., et al. 2014. Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities. Int. J. Nanomedicine 9: 4935–4951.
66. Jung, K.H., et al. 2014. Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo. Int. J. Pharm. 478: 251–257.
67. Guo, L., et al. 2015. Cell death pathway induced by resveratrol-bovine serum albumin nanoparticles in a human ovarian cell line. Oncol. Lett. 9: 1359–1363.
68. Kundu, J.K. & Y.J. Surh. 2008. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 269: 243–261.